Matching Items (3)
Filtering by
- All Subjects: Sensor
- Creators: Raupp, Gregory
Description
This work describes the development of a device for measuring CO2 in breath, which has applications in monitoring a variety of health issues, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and cardiovascular disease. The device takes advantage of colorimetric sensing technology in order to maintain a low cost and high user-friendliness. The sensor consists of a pH dye, reactive element, and base coated on a highly porous Teflon membrane. The transmittance of the sensor is measured in the device via a simple LED/photodiode system, along with the flow rate, ambient relative humidity, and barometric pressure. The flow is measured by a newly developed flow meter described in this work, the Confined Pitot Tube (CPT) flow meter, which provides a high accuracy with reduced flow-resistance with a standard differential pressure transducer. I demonstrate in this work that the system has a high sensitivity, high specificity, fast time-response, high reproducibility, and good stability. The sensor has a simple calibration method which requires no action by the user, and utilizes a sophisticated, yet lightweight, model in order to predict temperature changes on the sensor during breathing and track changes in water content. It is shown to be effective for measuring CO2 waveform parameters on a breath-by-breath basis, such as End-Tidal CO2, Alveolar Plateau Slope, and Beginning Exhalation Slope.
ContributorsBridgeman, Devon (Author) / Forzani, Erica S (Thesis advisor) / Nikkhah, Mehdi (Committee member) / Holloway, Julianne (Committee member) / Raupp, Gregory (Committee member) / Emady, Heather (Committee member) / Arizona State University (Publisher)
Created2017
Description
Cardiovascular disease is affecting millions of people worldwide and is the leading cause of death in the United States. This disease is closely related to the abnormal creatinine levels in blood. For this reason, there is a need for a low-cost point-of-care device that could measure the creatinine level in blood with the goal of managing and preventing cardiovascular disease. This project introduces a Molecular Reactive Lateral Flow Assay (MoReLFA) device that is aimed toward creatinine detection based on an optimized chemical reaction of creatinine and alkaline picrate. The device consists of different membranes that accommodate 50 microliters of fluid sample and carry out a colorimetric reaction, in which deposited-colored region is analyzed for Red, Green, and Blue (RGB) components via an image processing software. The color intensity from the RGB outputs was then studied and compared with a gold standard spectrophotometry-based technique. The results show that the MoReLFA sensor could successfully detect creatinine levels in standard solutions. The plot of the sensor color intensity against the absorbance from spectrophotometry shows a good correlation between the two methods (R2 = 0.96). Furthermore, the paper introduces the development of a RGB reader box that is portable and for easy assessment of RGB values. The color intensity from the box shows an increasing trend with increasing creatinine concentrations; and the coefficient of determination of this relationship is 0.85.
ContributorsNguyen, Ngan Anh (Author) / Raupp, Gregory (Thesis advisor) / Forzani, Erica (Thesis advisor) / Mora, Sabrina Jimena (Committee member) / Arizona State University (Publisher)
Created2022
Description
Abnormally low or high blood iron levels are common health conditions worldwide and can seriously affect an individual’s overall well-being. A low-cost point-of-care technology that measures blood iron markers with a goal of both preventing and treating iron-related disorders represents a significant advancement in medical care delivery systems. Methods: A novel assay equipped with an accurate, storable, and robust dry sensor strip, as well as a smartphone mount and (iPhone) app is used to measure total iron in human serum. The sensor strip has a vertical flow design and is based on an optimized chemical reaction. The reaction strips iron ions from blood-transport proteins, reduces Fe(III) to Fe(II), and chelates Fe(II) with ferene, with the change indicated by a blue color on the strip. The smartphone mount is robust and controls the light source of the color reading App, which is calibrated to obtain output iron concentration results. The real serum samples are then used to assess iron concentrations from the new assay and validated through intra-laboratory and inter-laboratory experiments. The intra-laboratory validation uses an optimized iron detection assay with multi-well plate spectrophotometry. The inter-laboratory validation method is performed in a commercial testing facility (LabCorp). Results: The novel assay with the dry sensor strip and smartphone mount, and App is seen to be sensitive to iron detection with a dynamic range of 50 - 300 µg/dL, sensitivity of 0.00049 µg/dL, coefficient of variation (CV) of 10.5%, and an estimated detection limit of ~15 µg/dL These analytical specifications are useful for predicting iron deficiency and overloads. The optimized reference method has a sensitivity of 0.00093 µg/dL and CV of 2.2%. The correlation of serum iron concentrations (N=20) between the optimized reference method and the novel assay renders a slope of 0.95, and a regression coefficient of 0.98, suggesting that the new assay is accurate. Lastly, a spectrophotometric study of the iron detection reaction kinetics is seen to reveal the reaction order for iron and chelating agent. Conclusion: The new assay is able to provide accurate results in intra- and inter- laboratory validations and has promising features of both mobility and low-cost.
ContributorsSerhan, Michael (Author) / Forzani, Erica (Thesis advisor) / Raupp, Gregory (Committee member) / Acharya, Abhinav (Committee member) / Hu, Tony (Committee member) / Smith, Barbara (Committee member) / Arizona State University (Publisher)
Created2020